Inactive Instrument

Highlights Medisun Precision Medicine Ltd.

Equities

Medisun Precision Medicine Ltd. acquired New Sonic Global Limited from Sun Medical Operation Company Limited for $3.8 million.	25/17/25	CI
Accurexa, Inc. Enters into a License Agreement with Medisun Holdings Limited to Use Medisun's NK Cell Technology	09/17/09	CI
Accurexa Inc. Enters into Sublicense Agreement with CNMRGS Inc	07/17/07	CI
Accurexa Partners with Stemimmune to Develop Stem Cell-Mediated Immunotherapy for Cancer Patients	18/16/18	CI
DelMar Pharmaceuticals and Accurexa to Collaborate in the Development of a Novel Combination Chemotherapy for the Local Treatment of Brain Cancer	07/16/07	CI
Accurexa, Inc. Enters into an Exclusive License Agreement with the Regents of the University of California	18/14/18	CI

No results for this search